Programme Implications
Cross-source consensus on Programme Implications from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Risks & contraindications
Highlighted claims
- The findings reinforce early HIV diagnosis, rapid ART initiation, clinical monitoring, and broader TPT uptake. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study
- Opportunistic infection screening and management should be strengthened because baseline opportunistic infections predicted mortality. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study
- Tailored interventions are especially important for older PLHIV and people with advanced disease. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study
- Structural barriers such as stigma, delayed health-seeking, and limited timely testing access should be addressed to reduce late presentation. — Survival and predictors of mortality among people living with HIV (PLHIV) on antiretroviral therapy in Ethiopia (2016–2023): a retrospective cohort study